Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis
Background: Metoclopramide and domperidone are prokinetic agents commonly used to treat gastrointestinal dysmotility disorders. This study aimed to evaluate the safety and associated side effects of prolonged-use metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility di...
Saved in:
Main Authors: | Saad Alkhowaiter (Author), Maha M. Al Rasheed (Author), Nuha Alammar (Author), Ammar Alotaibi (Author), Mansour Altuwaijri (Author), Suliman Alshankiti (Author), Mohammed A. Omair (Author), Majid Alsahafi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Insights into the Understanding of Gastrointestinal Dysmotility
by: Bodil Ohlsson, et al.
Published: (2007) -
New Insights into the Understanding of Gastrointestinal Dysmotility
by: Bodil Ohlsson, et al.
Published: (2007) -
Oral erythromycin for treatment of gastrointestinal dysmotility in premature infants
by: Armelia Moesri, et al.
Published: (2007) -
Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders
by: Rajan Singh, et al.
Published: (2022) -
Protective effect of oxytocin on vincristine-induced gastrointestinal dysmotility in mice
by: Shuang Li, et al.
Published: (2024)